DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Tech
Updated 1d ago
4153 logo

DIVA Laboratories, Ltd.TPEX:4153 Stock Report

Market Cap NT$1.9b
Updated 1d ago
Share Price
n/a
1Y-18.0%
7D1.8%
1D-0.2%
Portfolio Value
​
View

DIVA Laboratories, Ltd.

TPEX:4153 Stock Report

Market Cap: NT$1.9b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

DIVA Laboratories (4153) Stock Overview

Engages in the research, development, manufacture, and sale of medical devices and computer peripherals worldwide. More details

4153 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends2/6

Rewards

Price-To-Earnings ratio (19.5x) is below the Electronic industry average (27.2x)

Earnings have grown 28.9% per year over the past 5 years

Risk Analysis

Dividend of 6.26% is not well covered by earnings or free cash flows

High level of non-cash earnings

Does not have a meaningful market cap (NT$2B)


4153 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW427,144 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
427,144 investors already sharing narratives
NT$
Current Price
NT$31.9521.0% overvalued intrinsic discount
%/yr
Decrease
Increase
PastFuture-196m1b2016201920222025202620282031Revenue NT$1.0bEarnings NT$111.4m
Advanced
View all narratives

DIVA Laboratories, Ltd. Competitors

Arch Meter

Symbol: TWSE:4588
Market cap: NT$2.4b

Apex Material Technology

Symbol: TPEX:6899
Market cap: NT$2.1b

Mildex Optical

Symbol: TPEX:4729
Market cap: NT$1.5b

Taiwan Alpha Electronic

Symbol: TPEX:6204
Market cap: NT$2.5b

Price History & Performance

Summary of share price highs, lows and changes for DIVA Laboratories
Historical stock prices
Current Share PriceNT$31.95
52 Week HighNT$39.50
52 Week LowNT$29.00
Beta0.17
1 Month Change-3.18%
3 Month Change6.50%
1 Year Change-17.97%
3 Year Change-1.99%
5 Year Change26.04%
Change since IPO93.89%

Recent News & Updates

Recent updates

Analysis Article • Feb 28

Should You Be Impressed By DIVA Laboratories' (GTSM:4153) Returns on Capital?

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article • Dec 27

DIVA Laboratories, Ltd. (GTSM:4153) Stock's On A Decline: Are Poor Fundamentals The Cause?

With its stock down 17% over the past three months, it is easy to disregard DIVA Laboratories (GTSM:4153). To decide if...
Analysis Article • Nov 30

Is DIVA Laboratories (GTSM:4153) Likely To Turn Things Around?

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Shareholder Returns

4153TW ElectronicTW Market
7D1.8%1.4%2.3%
1Y-18.0%96.6%82.5%

Return vs Industry: 4153 underperformed the TW Electronic industry which returned 91.6% over the past year.

Return vs Market: 4153 underperformed the TW Market which returned 77.4% over the past year.

Price Volatility

Is 4153's price volatile compared to industry and market?
4153 volatility
4153 Average Weekly Movement2.5%
Electronic Industry Average Movement7.7%
Market Average Movement5.7%
10% most volatile stocks in TW Market11.0%
10% least volatile stocks in TW Market2.4%

Stable Share Price: 4153 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 4153's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1984n/aChen Genewww.diva.com.tw

DIVA Laboratories, Ltd. engages in the research, development, manufacture, and sale of medical devices and computer peripherals worldwide. The company provides endo/surgical displays for hybrid and other types of OR applications; color and mono displays for radiology applications; and touch and embedded display, as well as industrial displays. DIVA Laboratories, Ltd.

DIVA Laboratories, Ltd. Fundamentals Summary

How do DIVA Laboratories's earnings and revenue compare to its market cap?
4153 fundamental statistics
Market capNT$1.87b
Earnings (TTM)NT$95.99m
Revenue (TTM)NT$894.67m
19.5x
P/E Ratio
2.1x
P/S Ratio

Is 4153 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4153 income statement (TTM)
RevenueNT$894.67m
Cost of RevenueNT$637.02m
Gross ProfitNT$257.66m
Other ExpensesNT$161.66m
EarningsNT$95.99m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)1.64
Gross Margin28.80%
Net Profit Margin10.73%
Debt/Equity Ratio0%

How did 4153 perform over the long term?

See historical performance and comparison

Dividends

6.3%
Current Dividend Yield
122%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/18 04:43
End of Day Share Price 2026/09/18 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DIVA Laboratories, Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hsiu Chi LinMasterlink Securities Investment Advisory

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide